TF5890

TF5890 | TC3 XPlanar

A wizard makes initial commissioning fast and simple: scan the system, configure the geometry of the modules with the mouse, identify the movers, automatically link in TwinCAT. In ongoing operation, the software carries out the calculation of the mover position, precise position control, as well as monitoring and diagnostics. Each mover is identified by the application software with an axis number and the XYZ coordinates as well as the angles of rotation α, ß, or γ of these 3 axes. Helpful items of information such as current consumption, lag errors, temperature and many others simplify diagnostcis and enable integration of additional functions, such as weighing of products.

The mover motion is controlled by TwinCAT software. The system supports different levels of automation in 3 expansion stages.

Stage 1: The movers can be moved on a predefined 2D path with simple motion commands. All functions of the XTS system are available. In addition, movers can be lifted or lowered.

Stage 2: Different 2D paths can be defined. The movers can switch between these paths. All functions from stage 1 are included.

Stage 3: Fully automatic path calculation: The application software sends commands such as “Drive to Station 1” or “Wait in Zone B”. The software executes all other tasks such as path optimisation, collision avoidance, energy-saving operation and congestion avoidance. All functions from stage 2 are included.

Technical data TF5890
Required TC1250
Target system Windows 7/8/10
Ordering information
TF5890-0v80 software license, TwinCAT 3 XPlanar, TwinCAT 3 platform P80 (Very High Performance)
TF5890-0v81 software license, TwinCAT 3 XPlanar, TwinCAT 3 platform P81 (Many-core, 5-8 Cores)
TF5890-0v82 software license, TwinCAT 3 XPlanar, TwinCAT 3 platform P82 (Many-core, 9…16 Cores)
TF5890-0v83 software license, TwinCAT 3 XPlanar, TwinCAT 3 platform P83 (Many-core, 17…32 Cores)
TF5890-0v84 software license, TwinCAT 3 XPlanar, TwinCAT 3 platform P84 (Many-core, 33…64 Cores)
Product announcement
estimated market release 3rd quarter 2019